Juvenile arthritis, HLA-A2 and binding of DEK oncogene-peptides

Human Immunology

Volumn 59, Issue 7, 1998, Pages 443-450

  Forero, Leonardo ^a   Zwirner, Norberto W ^a   Fink, Chester W ^a   Fernández Viña, Marcelo A ^a   Stastny, Peter ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HLA SYSTEM; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ARTHRITIS, JUVENILE RHEUMATOID; AUTOANTIGENS; BINDING SITES; CHROMOSOMAL PROTEINS, NON-HISTONE; HLA-A2 ANTIGEN; HUMANS; OLIGOPEPTIDES; ONCOGENE PROTEINS; PROTEIN BINDING;

EID: 0031851539     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00034-2     Document Type: Article

References (15)

1. Fernández-Viña M., Fink C.W., Stastny P. HLA associations in juvenile arthritis. Clin Exp Reumathol. 12:1994;205.
2. Oen K., Petty R.R., Schroeder M.L. An association between HLA-A2 and juvenile rheumatoid arthritis girls. J Rheumatol. 9:1982;916.
3. Fink C.W., Fernández-Viña M., Stastny P. Clinical and genetic evidence that juvenile arthritis is not a single disease. Pediatric Reumathol. 42:1995;1155.
4. Szer I., Sierakowska H., Szer W. A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile arthritis. J Reumathol. 21:1994;2136.
5. Salter R.D., Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5:1986;943.
6. Parker K.C., Carreño B.M., Sestak L., Utz U., Biddison W.E., Coligan J.E. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. J Biol Chem. 267:1992;5451.
7. Zeh H.J. III, Leder G.H., Lotze M.T., Salter R.D., Tector M., Stuber G., Modrow S., Storkus W.J. Flow-cytometric determination of peptide-class I complex formation Identification of p53 peptides that bind to HLA-A2 . Hum Immunol. 39:1994;79.
8. Coligan E, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Electrophoretic separation of proteins. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current protocols in immunology. NY, Greene Publishing Associates, Inc. and John Wiley & Sons, Inc., New York, 1994.
9. Parker K.C., Bednarek M.A., Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptides side chains. J Immunol. 152:1994;163.
10. Rammensee H.G., Friede T., Stevanovic S. MHC ligands and peptide motifs, first listing. Immunogenetics. 41:1995;178.
11. D'Amaro J., Houbiers J.G.A., Drijfhout J.W., Brandt R.M.P., Schipper R., Bouves Bavinck J.N., Melief C.J.M., Kast W.M. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum Immunol. 43:1995;13.
12. Gianani R., Sarvetnick N. Viruses, cytokines, antigens, and autoimmunity. Proc Natl Acad Sci USA. 93:1996;2257.
13. Lanzavecchia A. How can cryptic epitopes trigger autoinimunity? J Exp Med. 181:1995;1945.
14. Barnaba V., Sinigaglia F. Molecular mimicry and T cell-mediated autoimmune disease. J Exp Med. 185:1997;1529.
15. Roudier C., Auger I., Roudier J. Molecular mimicry reflected through database screening serendipity or survival strategy? Immunol Today. 17:1996;357.